Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

Author:

Papapoulos Socrates1,Chapurlat Roland2,Libanati Cesar3,Brandi Maria Luisa4,Brown Jacques P5,Czerwiński Edward6,Krieg Marc‐Antoine7,Man Zulema8,Mellström Dan9,Radominski Sebastião C10,Reginster Jean‐Yves11,Resch Heinrich12,Ivorra José A Román13,Roux Christian14,Vittinghoff Eric15,Austin Matthew3,Daizadeh Nadia3,Bradley Michelle N3,Grauer Andreas3,Cummings Steven R16,Bone Henry G17

Affiliation:

1. Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands

2. INSERM UMR 1033, Université de Lyon, Lyon, France

3. Amgen Inc., Thousand Oaks, CA, USA

4. Department of Internal Medicine, University of Florence, Florence, Italy

5. Department of Medicine, Laval University and Rheumatology Division, CHUQ Research Centre, Laval University, Quebec City, QC, Canada

6. Krakow Medical Center, Krakow, Poland

7. Bone and Joint Department, University Hospital of Lausanne, Lausanne, Switzerland

8. Endocrinology Division, Centro TIEMPO, Buenos Aires, Argentina

9. Osteoporosis Clinic, Center for Bone Research, Sahlgrenska University Hospital, Göteborg, Sweden

10. Department of Internal Medicine, Universidade Federal do Paraná, Curitiba, Brazil

11. Bone and Cartilage Metabolism Unit, University of Liège, Liège, Belgium

12. Medical Department II, St. Vincent Hospital, Vienna, Austria

13. Rheumatology Unit, Hospital Universitario La Fe, Valencia, Spain

14. Department of Rheumatology, Cochin Hospital, Paris Descartes University, Paris, France

15. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA

16. San Francisco Coordinating Center, CPMC Research Institute, and University of California San Francisco, San Francisco, CA, USA

17. Michigan Bone and Mineral Clinic, Detroit, MI, USA

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3